Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets

PHASE3CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

April 30, 2013

Study Completion Date

July 31, 2013

Conditions
Primary Hypophosphatemic Rickets
Interventions
DRUG

Z-521

Trial Locations (4)

Unknown

Chiba Children's Hospital, Chiba

Kanagawa Children's Medical Center, Kanagawa

Osaka University Hospital, Osaka

Tokyo Metropolitan Children's Medical Center, Tokyo

Sponsors
All Listed Sponsors
lead

Zeria Pharmaceutical

INDUSTRY